Trump signs executive order to fast-track psychedelic drug research
President Trump signed an executive order easing research restrictions on psychedelic substances including psilocybin and LSD. The order aims to accelerate scientific studies into their potential therapeutic uses for mental health conditions.
Advertisement: Article Inline